COMMUNIQUÉS West-GlobeNewswire

Pharming Group reports third quarter 2026 financial results; strong revenue growth, Joenja APDS expansion and CVID topline data in November
27/10/2026
Third quarter 2026 total revenues increased by 21% to US$117.6 million, compared to third quarter 2025, exceeding market expectations RUCONEST® revenue increased by 14% to US$93.8 million, compared to third quarter 2025 [...]
Novartis delivered sales growth and core margin expansion in Q3; raised FY core operating income guidance
27/10/2026
Ad hoc announcement pursuant to Art. 53 LR Third quarter Q3 net sales grew +4% (cc ¹ , +4% USD), with core operating income ¹ +10% (cc, +11% USD) Sales growth driven by priority brands including Kisqali (+37% cc), [...]
Basilea raises full-year guidance 2026 and financial target for “Agenda 2030” and provides updates on late-stage clinical programs
27/10/2026
2026 operating profit expected to reach CHF 115 million (previously CHF 70 million) driven by higher than expected Cresemba and Zevtera-related revenue of CHF 250 million (previously CHF 210 million) Cumulative cash [...]
Idorsia seeks US label update for QUVIVIQ daytime functioning benefits – first patients enrolled in Dari-Dream
27/10/2026
Building on established clinical evidence, Dari-Dream is designed to further characterize the impact of QUVIVIQ on daytime functioning and support its inclusion in the US prescribing information. Allschwil, Switzerland [...]
Roche receives CE Mark for cobas® smart e immunoanalyser, completing a portfolio that brings central-lab precision to healthcare settings ranging from small clinics to large hospital laboratories
27/10/2026
The cobas smart e immunoanalyser – the newest addition to Roche’s industry-leading cobas immunoassay systems portfolio – is engineered to deliver central-lab performance in a footprint under one square metre. With a [...]
ONWARD Medical to Announce Third-Quarter 2026 Results on November 3, 2026
27/10/2026
EINDHOVEN, The Netherlands, Oct. 27, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and [...]
Major shareholder announcement
27/10/2026
Company announcement no. 42 - 26 27 October 2026 Notification of holding of treasury shares Pursuant to Section 31 of the Danish Capital Markets Act, it is hereby announced that as of 26 October 2026, NTG Nordic [...]
Purespring Therapeutics advances kidney-targeted gene therapy PS-003 towards the clinic in X-linked Alport Syndrome, with new preclinical and epidemiological data presented at ASN Kidney Week 2026
27/10/2026
PS-003 is designed to address the underlying genetic cause of X-linked Alport Syndrome (XLAS), and new preclinical data demonstrate the restoration of COL4A5, the key collagen protein absent or defective in X LAS PS-003 [...]
KFSH Strengthens Patient-Centered Care With ICHOM Accreditation
27/10/2026
RIYADH, Saudi Arabia, Oct. 27, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSH) has earned Level 1 accreditation from the International Consortium for Health Outcomes Measurement ( [...]
Cellectis présente de nouvelles données précliniques démontrant une édition efficace du gène APOC3 et une réduction marquée des triglycérides avec .HEAL-101 à l’ESGCT 2026
27/10/2026
Un taux d’édition in vivo du gène APOC3 humain atteignant 70% après une seule administration Une réduction de 76 % du taux de triglycérides après une dose unique dans un modèle murin de la maladie NEW YORK, 27 oct. 2026 [...]
Cellectis Presents Preclinical Data Highlighting Efficient APOC3 Editing and Marked Triglyceride Reduction with .HEAL-101 at ESGCT 2026
27/10/2026
70% in vivo editing of human APOC3 in a single administration 76% triglyceride reduction after a single dose in murine disease model NEW YORK, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS – Nasdaq [...]
Fangzhou’s AI-Powered Supply Chain Platform Recognized in 2026 for Pharmaceutical Distribution Best Practices
27/10/2026
GUANGZHOU, China, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven Internet healthcare solutions, was recently recognized for its AI-powered [...]
Save the Date: HUTCHMED to Host Expert Insights Event on Recent Savolitinib Clinical Data in Non-Small Cell Lung Cancer
27/10/2026
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Oct. 26, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“ HUTCHMED ”) (Nasdaq/AIM:HCM; HKEX:13) today announces an expert webcast, co-hosted with Citigroup Global [...]
RadNet, Inc. Announces Agreement to Acquire ONRAD, Inc.
26/10/2026
Adds a radiology professional services platform offering teleradiology and in-hospital staffing for hospitals and health systems Enables RadNet to seamlessly combine radiology professional services, AI-powered [...]
OraSure to Announce Third Quarter 2026 Financial Results and Host Earnings Call on November 9th
26/10/2026
BETHLEHEM, Pa., Oct. 26, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) announced today that it will report its third quarter 2026 financial results on Monday, November 9, 2026, after the market [...]
Clover Health to Participate in Upcoming UBS Global Healthcare Conference
26/10/2026
WILMINGTON, Del., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Interim Chief Financial Officer, Clay Thornton, [...]
Lycia Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
26/10/2026
SOUTH SAN FRANCISCO, Calif., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Lycia Therapeutics, Inc. (“Lycia”) (Nasdaq: LYCA), a clinical-stage biotechnology company focused on the discovery and development of novel therapeutics [...]
Park Dental Partners Announces Dates for Third Quarter 2026 Earnings Release and Conference Call
26/10/2026
MINNEAPOLIS, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK), a leading dental resource organization, today announced that it will report its financial results for the quarter ended September [...]
SL Science Holding Limited Reports First Half 2026 Financial Results
26/10/2026
Net revenue rose 23% to $1.39 million with gross margin expanding to 40.2%, driven by B2B distribution growth and reduction in purchase costs compared with last period due to establishment of stable relationships with [...]

Pages

Other news

Test 2

22/10/2026

Lorem ipsum

Test 1

22/10/2026

Lorem upsum